Trial Profile
A Single-Center, Randomised, 4-Period, Phase 1 Study to Evaluate the Pharmacokinetics, Safety and Tolerability, and Effect of Food on Pharmacokinetics Following Single Doses of MIV-711 Capsule and Tablet Formulations in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs MIV 711 (Primary)
- Indications Osteoarthritis
- Focus Pharmacokinetics
- Sponsors Medivir AB
- 27 Feb 2018 New trial record